New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 23, 2014
13:39 EDTTMO, PKI, BRKRThermo Fisher Q2 results bode well for PerkinElmer, Bruker, says Mizuho
After Thermo Fisher reported Q2 earnings and revenue that beat consensus, Mizuho said all but the Diagnostics segment had results above the firm's expectations and that the company's guidance raise was larger than it first appears after its Cole-Parmer divestiture is accounted for. Mizuho maintains its Buy rating and $150 price target on Thermo Fisher and said its results bode well for PerkinElmer (PKI) and Bruker (BRKR).
News For TMO;PKI;BRKR From The Last 14 Days
Check below for free stories on TMO;PKI;BRKR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 30, 2014
07:29 EDTTMOMichBio to hold a conference
Subscribe for More Information
September 17, 2014
13:58 EDTBRKRBruker management to meet with Leerink
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use